Home › Trial NCT00005818
SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
- Trial IDNCT00005818
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment68
- Start date2000-03
- ConditionsAdenocarcinoma of the Colon · Adenocarcinoma of the Rectum · Recurrent Colon Cancer · Recurrent Rectal Cancer · Stage III Colon Cancer · Stage III Rectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.